Publication | Open Access

Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

Metabolic SyndromeRenal FunctionRenal DiseaseKidney FailureDiabetesChronic Kidney DiseaseType 2Diabetic Kidney DiseaseDapa-ckd TrialMedicineNephrology